Literature DB >> 1696255

L-citrulline production from L-arginine by macrophage nitric oxide synthase. The ureido oxygen derives from dioxygen.

N S Kwon1, C F Nathan, C Gilker, O W Griffith, D E Matthews, D J Stuehr.   

Abstract

Previously proposed mechanisms for the production of L-citrulline from L-arginine by macrophage nitric oxide (NO.) synthase involve either hydrolysis of arginine or hydration of an intermediate and thus predict incorporation of water oxygen into L-citrulline. Macrophage NO. synthase was incubated with L-arginine, NADPH, tetrahydrobiopterin, FAD, and dithiothreitol in H2(18)/16O2. L-Citrulline produced in this reaction was analyzed with gas chromatography/mass spectrometry. Its mass spectrum matched that of L-citrulline generated in H2(16)O/16O2. The base fragment ion of m/z 99 was shown to contain the ureido carbonyl group by using L-[guanidino-13C]arginine as substrate. When the enzyme reaction was performed in H2(16)O/18O2, the base fragment ion shifted to m/z 101 with L-[guanidino-12C]arginine as the substrate and to m/z 102 with L-[guanidino-13C]arginine. These results indicate that the ureido oxygen of the L-citrulline product of macrophage NO.synthase derives from dioxygen and not from water.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696255

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme.

Authors:  C J Lowenstein; C S Glatt; D S Bredt; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 2.  Adventures in vascular biology: a tale of two mediators.

Authors:  S Moncada
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-05-29       Impact factor: 6.237

3.  N-hydroxylamine is not an intermediate in the conversion of L-arginine to an activator of soluble guanylate cyclase in neuroblastoma N1E-115 cells.

Authors:  S Pou; W S Pou; G M Rosen; E E el-Fakahany
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

4.  Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein.

Authors:  D J Stuehr; H J Cho; N S Kwon; M F Weise; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

Review 5.  Exploiting oxidative microenvironments in the body as triggers for drug delivery systems.

Authors:  Shivanjali Joshi-Barr; Caroline de Gracia Lux; Enas Mahmoud; Adah Almutairi
Journal:  Antioxid Redox Signal       Date:  2014-04-15       Impact factor: 8.401

6.  Hypoxia in Leishmania major skin lesions impairs the NO-dependent leishmanicidal activity of macrophages.

Authors:  Alexander Mahnke; Robert J Meier; Valentin Schatz; Julian Hofmann; Kirstin Castiglione; Ulrike Schleicher; Otto S Wolfbeis; Christian Bogdan; Jonathan Jantsch
Journal:  J Invest Dermatol       Date:  2014-02-28       Impact factor: 8.551

7.  Impairment of pulmonary-artery endothelium-dependent relaxation in chronic obstructive lung disease is not due to dysfunction of endothelial cell membrane receptors nor to L-arginine deficiency.

Authors:  A T Dinh-Xuan; J Pepke-Zaba; A Y Butt; G Cremona; T W Higenbottam
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

8.  Improvement of L-citrulline production in Corynebacterium glutamicum by ornithine acetyltransferase.

Authors:  N Hao; J Mu; N Hu; S Xu; M Yan; Y Li; K Guo; L Xu
Journal:  J Ind Microbiol Biotechnol       Date:  2014-12-10       Impact factor: 3.346

9.  Purification and characterization of nitric oxide synthase (NOSNoc) from a Nocardia species.

Authors:  Y Chen; J P Rosazza
Journal:  J Bacteriol       Date:  1995-09       Impact factor: 3.490

Review 10.  In search of a function for tetrahydrobiopterin in the biosynthesis of nitric oxide.

Authors:  B Mayer; E R Werner
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.